Search research articles
Contact Us
Filters
Showing results (41-50 of 90) with videos related to
Page
of 9
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
September 1, 1990
Adenocarcinoma of the esophagus and esophago-gastric junction: the effects of single and combined modalities on the survival and patterns of failure following treatment
R Whittington, L R Coia, D G Haller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 5, 2001
Phase II trial of dacarbazine (DTIC) in advanced pancreatic islet cell carcinoma. Study of the Eastern Cooperative Oncology Group-E6282
R K Ramanathan, A Cnaan, R G Hahn, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 1, 1991
Adjuvant therapy of resected adenocarcinoma of the pancreas
R Whittington, M P Bryer, D G Haller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1993
Hepatic toxicity associated with fluorouracil plus levamisole adjuvant therapy
C G Moertel, T R Fleming, J S Macdonald, et al.
American Journal of Clinical Oncology
|
October 1, 1989
A phase II study of carboplatin and CHIP in patients with metastatic colon carcinoma
R F Asbury, A Kramer, M Green, et al.
Medical Oncology (Northwood, London, England)
|
January 5, 2000
Phase II protocol for the evaluation of new treatments in patients with advanced gastric carcinoma: results of ECOG 5282
Y Novik, L M Ryan, D G Haller, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 1, 1983
The effect of adjuvant chemotherapy on cosmesis and complications in patients with breast cancer treated by definitive irradiation
B F Danoff, R L Goodman, J H Glick, et al.
American Journal of Clinical Oncology
|
April 1, 1994
An Eastern Cooperative Oncology Group phase II study of single agent DHAD, VP-16, aclacinomycin, or spirogermanium in metastatic pancreatic cancer
R F Asbury, A Cnaan, L Johnson, et al.
Cancer Treatment Reports
|
April 1, 1978
Phase II trial of 5-fluorouracil, adriamycin, and mitomycin C in advanced colorectal cancer
D G Haller, P V Woolley, J S Macdonald, et al.
American Journal of Clinical Oncology
|
December 18, 1998
A phase II trial and pharmacokinetic analysis of 96-hour infusional paclitaxel in patients with metastatic colorectal cancer
K Huang, D J Vaughn, L M Shaw, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 90) with videos related to
Sort By:
Page
of 9
International Journal of Radiation Oncology, Biology, Physics
|
September 1, 1990
Adenocarcinoma of the esophagus and esophago-gastric junction: the effects of single and combined modalities on the survival and patterns of failure following treatment
R Whittington, L R Coia, D G Haller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 5, 2001
Phase II trial of dacarbazine (DTIC) in advanced pancreatic islet cell carcinoma. Study of the Eastern Cooperative Oncology Group-E6282
R K Ramanathan, A Cnaan, R G Hahn, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 1, 1991
Adjuvant therapy of resected adenocarcinoma of the pancreas
R Whittington, M P Bryer, D G Haller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1993
Hepatic toxicity associated with fluorouracil plus levamisole adjuvant therapy
C G Moertel, T R Fleming, J S Macdonald, et al.
American Journal of Clinical Oncology
|
October 1, 1989
A phase II study of carboplatin and CHIP in patients with metastatic colon carcinoma
R F Asbury, A Kramer, M Green, et al.
Medical Oncology (Northwood, London, England)
|
January 5, 2000
Phase II protocol for the evaluation of new treatments in patients with advanced gastric carcinoma: results of ECOG 5282
Y Novik, L M Ryan, D G Haller, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 1, 1983
The effect of adjuvant chemotherapy on cosmesis and complications in patients with breast cancer treated by definitive irradiation
B F Danoff, R L Goodman, J H Glick, et al.
American Journal of Clinical Oncology
|
April 1, 1994
An Eastern Cooperative Oncology Group phase II study of single agent DHAD, VP-16, aclacinomycin, or spirogermanium in metastatic pancreatic cancer
R F Asbury, A Cnaan, L Johnson, et al.
Cancer Treatment Reports
|
April 1, 1978
Phase II trial of 5-fluorouracil, adriamycin, and mitomycin C in advanced colorectal cancer
D G Haller, P V Woolley, J S Macdonald, et al.
American Journal of Clinical Oncology
|
December 18, 1998
A phase II trial and pharmacokinetic analysis of 96-hour infusional paclitaxel in patients with metastatic colorectal cancer
K Huang, D J Vaughn, L M Shaw, et al.
Page
of 9